https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-442012-04-22 00:00:002021-11-15 14:43:58Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-102012-04-18 00:00:002019-02-15 09:21:30Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-06 / Acta Histochem. 2013 Jan;115(1):8-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-06 / Acta Histochem. 2013 Jan;115(1):8-152012-04-06 00:00:002019-07-16 13:14:45Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-05 / Cancer Immunol. Immunother. 2012 Nov;61(11):1929-39
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-05 / Cancer Immunol. Immunother. 2012 Nov;61(11):1929-392012-04-05 00:00:002019-02-15 08:52:15Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-02 / PLoS ONE 2012;7(4):e32614
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-02 / PLoS ONE 2012;7(4):e326142012-04-02 00:00:002019-02-15 08:46:34Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-28 / Korean J Hematol 2012 Mar;47(1):17-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-28 / Korean J Hematol 2012 Mar;47(1):17-272012-03-28 00:00:002019-02-15 08:50:44Cellular immunotherapy using dendritic cells against multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-23 / Lung Cancer 2012 Jul;77(1):140-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-23 / Lung Cancer 2012 Jul;77(1):140-52012-03-23 00:00:002019-07-16 13:13:18Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-642012-03-22 00:00:002019-02-15 08:35:56The blockade of immune checkpoints in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):265-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):265-772012-03-22 00:00:002019-02-15 08:39:58Cancer immunotherapy via dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-22 / Bioessays 2012 Jun;34(6):489-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-22 / Bioessays 2012 Jun;34(6):489-972012-03-22 00:00:002012-03-22 00:00:00Extracellular vesicles–vehicles that spread cancer genes
